earlycdt-lung.co.uk Report : Visit Site

Technical data of the earlycdt-lung.co.uk

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host earlycdt-lung.co.uk. Currently, hosted in United States and its service provider is GoDaddy.com LLC .

hl.co.uk 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called nginx containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

videos contact blog search lung cancer test early cdt-lung – test validation lung nodule – malignancy risk assessment lung nodule – test result interpretation lung cancer – early diagnosis lung cancer – general risk assessment general risk assessment – test result interpretation how to get early cdt-lung early cdt-lung – insurance & billing early cdt-lung – papers & publications early cdt-lung kit liver cancer test how to get early cdt-liver early cdt-liver – further literature early cdt-liver – insurance & billing about oncimmune leadership board of directors scientific advisory board science committee lung clinical advisory group press releases regulation & quality order early cdt tests order early cdt-lung order early cdt-liver contact us investors corporate governance regulatory newsflow share price and tools shareholder analysis analyst coverage results, reports & presentations corporate documents investor & advisor contacts aim rule 26 lung cancer test early cdt-lung – test validation lung nodule – malignancy risk assessment lung nodule – test result interpretation lung cancer – early diagnosis lung cancer – general risk assessment general risk assessment – test result interpretation how to get early cdt-lung early cdt-lung – insurance & billing early cdt-lung – papers & publications early cdt-lung kit liver cancer test how to get early cdt-liver early cdt-liver – further literature early cdt-liver – insurance & billing about oncimmune leadership board of directors scientific advisory board science committee lung clinical advisory group press releases regulation & quality order early cdt tests order early cdt-lung order early cdt-liver contact us investors corporate governance regulatory newsflow share price and tools shareholder analysis analyst coverage results, reports & presentations corporate documents investor & advisor contacts aim rule 26 home oncimmune patient care program autoantibody technology privacy policy early cdt-lung order form for the us blog lung cancer test early cdt-lung – test validation lung nodule – malignancy risk assessment lung nodule – test result interpretation lung cancer – early diagnosis lung cancer – general risk assessment general risk assessment – test result interpretation how to get early cdt-lung early cdt-lung – insurance & billing early cdt-lung – papers & publications early cdt-lung kit liver cancer test how to get early cdt-liver early cdt-liver – further literature early cdt-liver – insurance & billing about oncimmune leadership board of directors scientific advisory board science committee lung clinical advisory group press releases regulation & quality order early cdt tests order early cdt-lung order early cdt-liver contact us investors corporate governance regulatory newsflow share price and tools shareholder analysis analyst coverage results, reports & presentations corporate documents investor & advisor contacts aim rule 26 oncimmune is a leading early cancer testing business. our proprietary technology can be used for most solid tumor types read more... our simple blood test for lung cancer can be used in conjunction with ct and other imaging to assess the risk of having lung cancer read more... early cdt®-lung significantly aids the malignancy risk assessment of lung nodules. our lung cancer test has high specificity and ppv and so can be used to rule-in for lung cancer. read more... early cdt®-lung test is available now in the us, europe, asia and the middle east order now... early cdt®-liver is a simple blood test to aid detection and confirmation of hcc in association with imaging, in high-risk patients with liver lesions of all sizes read more... read more about our lung cancer test using early cdt-lung for nodule risk assessment latest news oncimmune publishes study showing cost-effectiveness of early cdt-lung test in early detection of lung cancer in patients with indeterminate pulmonary nodules read more order early cdt tests read more about our liver cancer test early cdt-lung case study - dr. kucera please read the following statement carefully electronic versions of the materials you are seeking to access are being made available on this website by oncimmune holdings plc (the “company”). these materials are not directed to nor are they intended for access by persons located or resident in the united states, australia, canada, south africa, japan or any other jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction. none of the securities of company discussed or referred to in the materials you are seeking to access have been registered under the us securities act or 1933, as amended (the “securities act”) and may not be offered, sold, pledged or otherwise transferred except (1) in an offshore transaction meeting the requirements of rule 903 or rule 904 of regulation s under the securities act, (2) pursuant to an effective registration statement under the securities act, or (3) pursuant to an available exemption from the registration requirements of the securities act, in each case in accordance with all applicable securities laws. by clicking the “submit” button below you confirm that you (1) have read and understood the information set out above, (2) agree to be bound by its terms, (3) are not located in the united states and do not have a registered address in, and are not resident or located in, australia, canada, south africa or japan and (4) are permitted under applicable law and regulation to proceed to the following parts of this website. please click on the button below to confirm that you have read, understood and agree with the disclaimer above. yes, i accept no, i don't accept we use cookies to improve your visit. by continuing to browse our site, you accept our cookie policy. our cookie policy cookie policy okay, thanks terms & conditions | cookies oncimmune limited clinical sciences building, nottingham city hospital hucknall road, nottingham, ng5 1pb, united kingdom +44 (0) 115 82 31869 oncimmune (usa) llc 8960 commerce drive, building #6, de soto, ks 66018, usa +1 913 583 9000   

URL analysis for earlycdt-lung.co.uk

http://oncimmune.com/investors/corporate-documents/
http://oncimmune.com/home/blog/
http://oncimmune.com/about-oncimmune/leadership/
http://oncimmune.com/liver-cancer-test/earlycdt-liver-further-literature/
http://oncimmune.com/liver-cancer-test/
http://oncimmune.com/home/oncimmune-patient-care-program/
http://oncimmune.com/about-oncimmune/board-of-directors/
http://oncimmune.com/lung-cancer-test/earlycdt-lung-insurance-billing/
http://oncimmune.com/lung-cancer-test/earlycdt-lung-how-it-works/
http://oncimmune.com/terms-and-conditions/
http://oncimmune.com/home/privacy-policy/
http://oncimmune.com/lung-cancer-test/lung-nodule-malignancy-risk-assessment/
http://oncimmune.com/investors/
http://oncimmune.com/home/testimonial-videos/
http://oncimmune.com/liver-cancer-test/how-to-get-earlycdt-liver/

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain name:
earlycdt-lung.co.uk

Data validation:
Nominet was able to match the registrant's name and address against a 3rd party data source on 22-Aug-2016

Registrar:
GoDaddy.com, LLP. [Tag = GODADDY]
URL: http://uk.godaddy.com

Relevant dates:
Registered on: 06-Apr-2009
Expiry date: 06-Apr-2019
Last updated: 23-Mar-2017

Registration status:
Registered until expiry date.

Name servers:
ns65.domaincontrol.com
ns66.domaincontrol.com

WHOIS lookup made at 09:00:49 06-Jul-2018

--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:

Copyright Nominet UK 1996 - 2018.

You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at https://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.

  REFERRER http://www.nominet.org.uk

  REGISTRAR Nominet UK

SERVERS

  SERVER co.uk.whois-servers.net

  ARGS earlycdt-lung.co.uk

  PORT 43

  TYPE domain

DOMAIN

SPONSOR
GoDaddy.com, LLP. [Tag = GODADDY]
URL: http://uk.godaddy.com
Relevant dates:

  CREATED 06-Apr-2009

  CHANGED 23-Mar-2017

STATUS
Registered until expiry date.

NSERVER

  NS65.DOMAINCONTROL.COM 216.69.185.43

  NS66.DOMAINCONTROL.COM 173.201.70.43

  NAME earlycdt-lung.co.uk

DISCLAIMER
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2018.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at https://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.

  REGISTERED no

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .